Advertisement
News
Advertisement

Study: Kips Bay begins U.S. feasibility trial for vascular mesh

Mon, 08/27/2012 - 12:30pm
Mass Device

Kips Bay Medical launches clinical trials in Europe to support FDA investigational device exemption for eSVS vascular mesh.

Kips Bay Medical logo

Kips Bay Medical (NSDQ:KIPS) launched the 1st feasibility trials aimed at gaining FDA investigational device clearance for its eSVS vascular mesh.

The eSVS is designed to help keep vein grafts open in patients undergoing coronary artery bypass surgery, according to the company's brochure.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading